Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
about
Lithium: the pharmacodynamic actions of the amazing ionMitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentAffective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disordersEfficacy of antimanic treatments: meta-analysis of randomized, controlled trialsGray matter volume in schizophrenia and bipolar disorder with psychotic features5-HT(1A) receptor function in major depressive disorderA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsBrain Structural Effects of Psychopharmacological Treatment in Bipolar DisorderParallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerabilityMolecular actions and clinical pharmacogenetics of lithium therapyStress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children.Neuropsychological dysfunction in bipolar affective disorder: a critical opinion.Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.The structural neuroimaging of bipolar disorder.Functional neuroimaging studies of bipolar disorder: examining the wide clinical spectrum in the search for disease endophenotypes.Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication.Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder.Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats.Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind.Insular and hippocampal gray matter volume reductions in patients with major depressive disorder.Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress.Impaired inter-hemispheric integration in bipolar disorder revealed with brain network analyses.A Ventral Prefrontal-Amygdala Neural System in Bipolar Disorder: A View from Neuroimaging ResearchDisturbances of visual motion perception in bipolar disorder.Valproic acid protects neurons and promotes neuronal regeneration after brachial plexus avulsion.Neuroplasticity and cellular resilience in mood disorders.The role of tau kinases in Alzheimer's disease.Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study.The underlying neurobiology of bipolar disorderProteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study.Lithium long-term treatment in mood disorders: clinical and genetic predictors.First-episode mania: a neglected priority for early intervention.Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics.Synaptic plasticity and mood disorders.Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression.NEUROBIOLOGY OF ADULT AND TEENAGE SUICIDEEpigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample.Antidepressants and neuroplasticity.
P2860
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
P2860
Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Clinical and preclinical evide ...... t of manic-depressive illness.
@en
Clinical and preclinical evide ...... t of manic-depressive illness.
@nl
type
label
Clinical and preclinical evide ...... t of manic-depressive illness.
@en
Clinical and preclinical evide ...... t of manic-depressive illness.
@nl
prefLabel
Clinical and preclinical evide ...... t of manic-depressive illness.
@en
Clinical and preclinical evide ...... t of manic-depressive illness.
@nl
P2093
P1476
Clinical and preclinical evide ...... t of manic-depressive illness.
@en
P2093
P304
P356
10.1016/S0006-3223(00)00979-3
P407
P577
2000-10-01T00:00:00Z